Cargando…

Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages

BACKGROUND: Cancer-testis antigens (CTAs) and tumour-associated antigens (TAAs) are frequently expressed in hepatocellular carcinoma (HCC); however, the role of tumour-antigen-specific T cell immunity in HCC progression is poorly defined. We characterized CTA- and TAA-specific T cell responses in di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zang, Chaoran, Zhao, Yan, Qin, Ling, Liu, Guihai, Sun, Jianping, Li, Kang, Zhao, Yanan, Sheng, Shoupeng, Zhang, Honghai, He, Ning, Zhao, Peng, Wang, Qi, Li, Xi, Peng, Yanchun, Dong, Tao, Zhang, Yonghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428121/ https://www.ncbi.nlm.nih.gov/pubmed/34496797 http://dx.doi.org/10.1186/s12885-021-08720-9

Ejemplares similares

Genomic DNA methylation profiling indicates immune response following thermal ablation treatment for HBV-associated hepatocellular carcinoma
por: Zhao, Yanan, et al.
Publicado: (2020)

Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation
por: Zang, Chaoran, et al.
Publicado: (2022)

Nomogram established on account of Lasso-Cox regression for predicting recurrence in patients with early-stage hepatocellular carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

A Novel Scoring System for Patients with Recurrence of Hepatocellular Carcinoma After Undergoing Minimal Invasive Therapies
por: Wang, Qi, et al.
Publicado: (2019)

Dynamic Changes of Cytokine Profiles and Their Correlation With Tumor Recurrence Following Thermal Ablation in Hepatocellular Carcinoma
por: Guo, Dandan, et al.
Publicado: (2023)

A CpG Methylation Signature as a Potential Marker for Early Diagnosis of Hepatocellular Carcinoma From HBV-Related Liver Disease Using Multiplex Bisulfite Sequencing
por: Li, Kang, et al.
Publicado: (2021)

Multiple T-cell responses are associated with better control of acute HIV-1 infection: An observational study
por: Sun, Jianping, et al.
Publicado: (2016)

Distinctive pattern of AHNAK methylation level in peripheral blood mononuclear cells and the association with HBV‐related liver diseases
por: Sun, Libo, et al.
Publicado: (2018)

Metabolomic Profiles for HBV Related Hepatocellular Carcinoma Including Alpha-Fetoproteins Positive and Negative Subtypes
por: Sun, Jianping, et al.
Publicado: (2019)

A Nomogram Prediction of Length of Hospital Stay in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study
por: Li, Kang, et al.
Publicado: (2021)

T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell
por: Liu, Sai, et al.
Publicado: (2019)

The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation
por: Li, Kang, et al.
Publicado: (2020)

Identification and analysis of tumour-associated antigens in hepatocellular carcinoma
por: Shi, Y-Y, et al.
Publicado: (2005)

High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults
por: Qin, Ling, et al.
Publicado: (2018)

Identification of an Immune-Related Prognostic Predictor in Hepatocellular Carcinoma
por: Wu, Lei, et al.
Publicado: (2020)

The monocyte to lymphocyte ratio not only at baseline but also at relapse predicts poor outcomes in patients with hepatocellular carcinoma receiving locoregional therapy
por: Wang, Qi, et al.
Publicado: (2022)

The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study
por: Wang, Qi, et al.
Publicado: (2021)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma
por: Chen, Gui-Xing, et al.
Publicado: (2020)

USP1 modulates hepatocellular carcinoma progression via the Hippo/TAZ axis
por: Liu, Dongyi, et al.
Publicado: (2023)

FOS-like antigen 1 is a prognostic biomarker in hepatocellular carcinoma
por: Li, Li, et al.
Publicado: (2019)

Percutaneous thermal ablation combined with transcatheter arterial chemoembolization for hepatitis C virus-related hepatocellular carcinoma: Efficacy and survival
por: Sun, Yu, et al.
Publicado: (2022)

Development and validation of a nomogram to predict the recurrence of hepatocellular carcinoma patients with dynamic changes in AFP undergoing locoregional treatments
por: Sun, Yu, et al.
Publicado: (2023)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer
por: Yang, Hong-Bin, et al.
Publicado: (2015)

Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma
por: Zhang, Aiying, et al.
Publicado: (2016)

Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area
por: Sideras, K, et al.
Publicado: (2015)

Prognostic significance of globulin/low-density lipoprotein ratio in patients with hepatocellular carcinoma after local ablative therapy: a retrospective cohort study
por: Sun, Yu, et al.
Publicado: (2023)

Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner
por: Li, Qiaoqiao, et al.
Publicado: (2012)

Microscopic Tumour Classification by Digital Mammography
por: Yang, Jingjing, et al.
Publicado: (2021)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
por: Shao, Bing, et al.
Publicado: (2018)

Interferon-Induced Transmembrane Protein 3 Expression Upregulation Is Involved in Progression of Hepatocellular Carcinoma
por: Hou, Yuli, et al.
Publicado: (2021)

Distinct expression and prognostic values of the replication protein A family in gastric cancer
por: Zhang, Yujie, et al.
Publicado: (2020)

Mechanisms of portal vein tumour thrombus formation and development in patients with hepatocellular carcinoma
por: Li, Zhenli, et al.
Publicado: (2023)

LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytes.
por: Ferrarini, M., et al.
Publicado: (1990)

Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'
por: Grizzi, F, et al.
Publicado: (2016)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Integrated Analysis of Transcriptome and Metabolome Reveals Distinct Responses of Pelteobagrus fulvidraco against Aeromonas veronii Infection at Invaded and Recovering Stage
por: Ning, Xianhui, et al.
Publicado: (2022)

Evidence of Distinct Tumour-Propagating Cell Populations with Different Properties in Primary Human Hepatocellular Carcinoma
por: Colombo, Federico, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_4mgcg6r3mrd2k86f15d22sm5ua